Posted by
on
With the extreme rise in Medicare Advantage (MA) plan marketing misconduct, and the ongoing mountain of prior authorizations and other barriers to care beneficiaries have long experienced in MA plans, the Centers for Medicare and Medicaid Services’ (CMS) new final rule announced in April is good news for all. The final rule will “strengthen Medicare […]
Filed Under:
Posted by
on
Have you ever wondered why private insurance companies are allowed to use the word “Medicare” in their title and branding, even though they are NOT Medicare? Even the word “advantage” in “Medicare Advantage” plans can be misleading. Who has the advantage? While monthly premiums may be cheaper than some Medigap plans monthly premiums, when intensive […]
Filed Under:
Posted by
on
In early November, the Senate Finance Committee Chairman Ron Wyden, D-Ore released a report documenting the substantial rise in agent/broker marketing fraud and enrollment abuses for Medicare Advantage plans. The report calls for significant action from the Centers for Medicare and Medicaid Services (CMS) to halt this trend and protect our country’s Medicare beneficiaries. The […]
Filed Under:
Posted by
on
In late April, the Centers for Medicare and Medicaid Services (CMS) issued finalized rules to both strengthen consumer protections in Medicare Advantage and Part D drug plans, and reduce out-of-pocket drug costs for beneficiaries. As summarized in CMS’ recent fact sheet, this final rule revises the MA and Part D regulations related to marketing and […]
Filed Under:
Posted by
on
California Health Advocates worked together with Center for Medicare Advocacy to submit comments on the proposed rule for Medicare Part C and D. While we wholeheartedly support several of the Centers for Medicare and Medicaid Services’ (CMS’) stated goals of the proposed rule, namely to “strengthen consumer protections to ensure MA and Part D beneficiaries […]